# PubMed record PMID 41023931

> PeptideScanner retained PubMed bibliographic metadata for PMID 41023931 at 2026-07-30T16:14:12.886Z. PubMed recorded a metadata revision date of 2026-06-26 and an Entrez history date of 2025-09-30. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-41023931-abaloparatide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-06-26
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41023931-abaloparatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-41023931-abaloparatide-v1.json
- Content SHA-256: `415e3b20430ed44d288a0aa7aef4ac404d2a2618288211d46a52562506380390`

## Claims and source pins

### Headline

PubMed record PMID 41023931 ([`pubmed-observation-pmid-41023931-2026-06-26-9b3f051e3fe8`](#source-pubmed-observation-pmid-41023931-2026-06-26-9b3f051e3fe8))

### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 41023931 at 2026-07-30T16:14:12.886Z. PubMed recorded a metadata revision date of 2026-06-26 and an Entrez history date of 2025-09-30. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41023931-2026-06-26-9b3f051e3fe8`](#source-pubmed-observation-pmid-41023931-2026-06-26-9b3f051e3fe8))

### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 41023931 at 2026-07-30T16:14:12.886Z. PubMed recorded a metadata revision date of 2026-06-26 and an Entrez history date of 2025-09-30. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41023931-2026-06-26-9b3f051e3fe8`](#source-pubmed-observation-pmid-41023931-2026-06-26-9b3f051e3fe8))

### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41023931-2026-06-26-9b3f051e3fe8`](#source-pubmed-observation-pmid-41023931-2026-06-26-9b3f051e3fe8))

## Sources

<a id="source-pubmed-observation-pmid-41023931-2026-06-26-9b3f051e3fe8"></a>
- **PubMed record PMID 41023931 · retained source version 1:2026-06-26:current:9b3f051e3fe8458d997d2d23e5d7c291ae1835668c74595d67a930c8bc94d406** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41023931/) (`pubmed-observation-pmid-41023931-2026-06-26-9b3f051e3fe8`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "PubMed record PMID 41023931." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-41023931-abaloparatide-v1.json SHA-256: 415e3b20430ed44d288a0aa7aef4ac404d2a2618288211d46a52562506380390.